80
Participants
Start Date
September 30, 2012
Primary Completion Date
September 30, 2018
Study Completion Date
October 31, 2018
Group A: Intramuscular
"Intramuscular BMAC application The study subjects in the Group A will receive a treatment of 35ml BMAC administered intramuscularly into the affected limb, in individual punctures of 1 ml.~The punctures will be applied into the crural muscle around the defect, the procedure takes approx. 60 minutes."
Group B: Intraarterial
Intraarterial BMAC application The study subjects in the Group B will receive a treatment of 35ml BMAC administered intraarterially into the affected limb.
Group C: Intravenous
Group C: Intravenous The study subjects in the Group C will receive a treatment of 35ml BMAC administered intravenously into the affected limb.
Group D: Surgical endovascular treatment with maximum medicamentous treatment
Group D: Control Group Control Group - no experimental intervention, standard endovascular treatment or bypass surgery or maximum medicamentous treatment
University Hospital Ostrava, Ostrava
Ministry of Health, Czech Republic
OTHER_GOV
Regional Council of the Moravian-Silesian region, KU MSK
UNKNOWN
University Hospital Ostrava
OTHER